Olaparib and temozolomide in desmoplastic small round cell tumors: a promising combination in vitro and in vivo
Anke van Erp(Radboud University Nijmegen), Winette T.A. van der Graaf(Radboud University Medical Center)
Cited by 27
Related Papers
Predicting IGF-1R Therapy Response in Bone Sarcomas: Immuno-SPECT Imaging with Radiolabeled R1507
|Clinical Cancer Research|2011|42
Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
|Targeted Oncology|2017|39
Temsirolimus combined with cisplatin or bevacizumab is active in osteosarcoma models
|International Journal of Cancer|2014|21